WO2001097815A3 - Verwendung von glukokortikosteroiden zur herstellung eines medikamentes für die behandlung von haarschwund - Google Patents

Verwendung von glukokortikosteroiden zur herstellung eines medikamentes für die behandlung von haarschwund Download PDF

Info

Publication number
WO2001097815A3
WO2001097815A3 PCT/EP2001/007110 EP0107110W WO0197815A3 WO 2001097815 A3 WO2001097815 A3 WO 2001097815A3 EP 0107110 W EP0107110 W EP 0107110W WO 0197815 A3 WO0197815 A3 WO 0197815A3
Authority
WO
WIPO (PCT)
Prior art keywords
oligotrichia
treat
glucocorticosteroids
medicament
producing
Prior art date
Application number
PCT/EP2001/007110
Other languages
English (en)
French (fr)
Other versions
WO2001097815A2 (de
Inventor
Moussa Ben Mohammed Willy Ben
Original Assignee
Moussa Ben Mohammed Willy Ben
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10050527A external-priority patent/DE10050527A1/de
Application filed by Moussa Ben Mohammed Willy Ben filed Critical Moussa Ben Mohammed Willy Ben
Priority to AU72503/01A priority Critical patent/AU7250301A/en
Publication of WO2001097815A2 publication Critical patent/WO2001097815A2/de
Publication of WO2001097815A3 publication Critical patent/WO2001097815A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Zur Lösung der Aufgabe, ein Mittel zur Behandlung von Haarschwund zu finden, wird die Verwendung eines Mittels umfassend, wobei R1 = O; H, OH; H¿2?; H, Cl; H, F; H, CH3; CH2; H, C2H5; R?2 = H¿2; CH2; H, CH3; H, OH; H, C2H5; H, Cl; H, F; O; R3 = H; H¿2?; H, OH; H, CH3; H, C2H5; H, Cl; H, F; Cl; F; O; OH; R?4¿ = F; Cl; H; H¿2?; OH; H, OH; H, CH3; H, C2H5; O; CH2; H, Cl; H, F; R?5¿ = H; F; Cl; OH; vorgeschlagen.
PCT/EP2001/007110 2000-06-22 2001-06-22 Verwendung von glukokortikosteroiden zur herstellung eines medikamentes für die behandlung von haarschwund WO2001097815A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU72503/01A AU7250301A (en) 2000-06-22 2001-06-22 Use of glucocorticosteroids for producing a medicament to treat oligotrichia

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE10029561 2000-06-22
DE10029561.4 2000-06-22
DE10050527.9 2000-10-11
DE10050527A DE10050527A1 (de) 2000-06-22 2000-10-11 Verwendung von Glukokortikosteroiden zur Herstellung eines Medikamentes für die Behandlung von Haarschwund

Publications (2)

Publication Number Publication Date
WO2001097815A2 WO2001097815A2 (de) 2001-12-27
WO2001097815A3 true WO2001097815A3 (de) 2002-04-04

Family

ID=26006100

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/007110 WO2001097815A2 (de) 2000-06-22 2001-06-22 Verwendung von glukokortikosteroiden zur herstellung eines medikamentes für die behandlung von haarschwund

Country Status (2)

Country Link
AU (1) AU7250301A (de)
WO (1) WO2001097815A2 (de)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2523820A1 (de) * 1975-05-10 1976-11-11 Otto Wagner Haarwuchsmittel
GB1487545A (en) * 1975-05-11 1977-10-05 Dso Pharmachim Dermatological composition
DE2819129A1 (de) * 1978-04-29 1979-11-15 Koehler Valentin Mittel zur behandlung nicht-infektioeser hauterkrankungen
GB2167957A (en) * 1984-12-07 1986-06-11 Yoshiaki Oshima Hair growth stimulating compositions
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
US5767104A (en) * 1989-04-20 1998-06-16 Bar-Shalom; Daniel Use of sulfated saccharides to treat baldness
WO1998041232A2 (en) * 1997-03-18 1998-09-24 Basf Aktiengesellschaft Compositions for modulating responsiveness to corticosteroids
WO2001019373A2 (en) * 1999-09-17 2001-03-22 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2523820A1 (de) * 1975-05-10 1976-11-11 Otto Wagner Haarwuchsmittel
GB1487545A (en) * 1975-05-11 1977-10-05 Dso Pharmachim Dermatological composition
DE2819129A1 (de) * 1978-04-29 1979-11-15 Koehler Valentin Mittel zur behandlung nicht-infektioeser hauterkrankungen
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
GB2167957A (en) * 1984-12-07 1986-06-11 Yoshiaki Oshima Hair growth stimulating compositions
US5767104A (en) * 1989-04-20 1998-06-16 Bar-Shalom; Daniel Use of sulfated saccharides to treat baldness
WO1998041232A2 (en) * 1997-03-18 1998-09-24 Basf Aktiengesellschaft Compositions for modulating responsiveness to corticosteroids
WO2001019373A2 (en) * 1999-09-17 2001-03-22 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
KERN F ET AL: "Alopecia areata. Immunologic studies and treatment with prednisone.", ARCHIVES OF DERMATOLOGY, (1973 MAR) 107 (3) 407-12., XP001035055 *
OLSEN E A ET AL: "Systemic steroids with or without 2% topical minoxidil in the treatment o alopecia areata.", ARCHIVES OF DERMATOLOGY, (1992 NOV) 128 (11) 1467-73., XP001035068 *
SHARMA V K ET AL: "Twice weekly 5 mg dexamethasone oral pulse in the treatment of extensive alopecia areata.", JOURNAL OF DERMATOLOGY, (1999 SEP) 26 (9) 562-5., XP001035069 *
SHARMA V K: "Pulsed administration of corticosteroids in the treatment of alopecia areata.", INTERNATIONAL JOURNAL OF DERMATOLOGY, (1996 FEB) 35 (2) 133-6., XP001035073 *
UNGER W P ET AL: "Corticosteroids in the treatment of alopecia totalis. Systemic effects.", ARCHIVES OF DERMATOLOGY, (1978 OCT) 114 (10) 1486-90., XP001035057 *

Also Published As

Publication number Publication date
WO2001097815A2 (de) 2001-12-27
AU7250301A (en) 2002-01-02

Similar Documents

Publication Publication Date Title
WO2002032898A3 (de) Neue anticholinergika, verfahren zu deren herstellung und deren verwendung als arzneimittel
MXPA03000386A (es) Imidazolios y tiazolios substituidos con cianometilo y tratamientos de desordenes asociados con la maduracion de la proteina.
BE2011C028I2 (en) Macrocyclic analogs and methods of their use and preparation
DE60100032D1 (de) Kosmetisches Reinigungsmittel
GB0007405D0 (en) Compounds
WO2002101007A3 (en) Antipathogenic benzamide compounds
BR0112725A (pt) Composição de verniz antimicótico para unha
AU2001260332A1 (en) Micronised barium sulphate
CA2222498A1 (en) Aqueous hand disinfectant composition comprising a lower alcohol and a diol
JPS57102813A (en) Perfume composition
WO2001072728A3 (en) Novel piperazine derivatives
WO2001066564A3 (en) Gamma-secretase inhibitors
AU2001262475A1 (en) Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
EP1340755A4 (de) Mittel mit wirkung gegen helicobacter
WO2002094020A8 (de) Verwendung von triazolopyrimidin-derivaten als mikrobizide im materialschutz
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
WO2000039083A3 (en) Pyrazole compounds and uses thereof
EA200300597A1 (ru) Бифенилкарбоксамиды, полезные в качестве снижающих содержание липидов агентов
WO1999050269A3 (de) Porphyrine und ihre verwendung als phptosensitizer
WO2002096358A3 (en) Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method
AU2001249684A1 (en) Nasal administration of agents for the treatment of gastroparesis
WO1999012933A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
WO2001009122A3 (en) Serotonergic benzofurans
SE0004101D0 (sv) New use
WO2002043715A3 (de) Verwendung von 1-phenyl-3-dimethylamino-propanverbindungen zur therapie der harninkontinenz

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP